Encephalitis Treatment Market, By Type (Primary Encephalitis, Secondary Encephalitis), By Treatment (Antiviral Agents, Steroid Injection, Antibiotics, Immunoglobulin Therapy, Plasmapheresis, Others), By Symptoms (Fever, Drowsiness, Headaches, Personality Changes, Irritability, Confusion, Weakness, Seizures, Others), By End User (Clinic, Hospital, Others), By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Encephalitis Treatment Market size was valued at USD 20,108.9 Million in 2022, expanding at a CAGR of 5.3% from 2023 to 2030.
An infection or an inflammatory reaction that affects the brain\'s active tissues might result in encephalitis. The goal of encephalitis treatment is to reduce head swelling and avert complications. Intravenous antibiotics can be administered to treat encephalitis if a bacterial infection is to blame. Herpes-related encephalitis is treated with supportive care and intravenous antiviral drugs including acyclovir. The patient should also be kept hydrated, their temperature should be reduced, and seizures should be treated, and any pressure in their skull should be eased.
Encephalitis Treatment Market- Market Dynamics
- Growing prevalence of encephalitis to propel market growth
An increase in encephalitis cases is anticipated to fuel the global market for encephalitis treatments. A type of lingering brain inflammation that becomes worse over time is called CFE. The cerebral hemisphere of the brain is often affected by inflammation, which causes severe epileptic activity such as recurring focal seizures. Because of the ongoing brain inflammation, people with CFE may have irreparable brain damage, loss of motor abilities, and mental deterioration. The sickness mostly affects children between the ages of 2 and 10, and there have only been 200–500 recorded cases worldwide. Thereby, the aforementioned facts support the market growth during the forecast period.
Encephalitis Treatment Market- Key Insights
- As per the analysis shared by our research analyst, the global Encephalitis Treatment market is estimated to grow annually at a CAGR of around 5.3% over the forecast period (2023-2030)
- The Encephalitis Treatment industry is projected to grow at a significant rate owing to the high prevalence of encephalitis across the globe
- Based on type segmentation, the primary segment is expected to dominate the market during the forecast period
- Based on region, North America is expected to dominate the market over the forecast period
Encephalitis Treatment Market- Segmentation Analysis:
The Global Encephalitis Treatment Market is segmented based on type, treatment, symptoms, end user, and Region.
Based on type, the market is bifurcated into primary and secondary. The primary segment is expected to dominate the market during the forecast period. The segment growth is attributed to the growing prevalence of primary encephalitis over secondary encephalitis. Primary encephalitis refers to cases where the inflammation of the brain is directly caused by an infectious agent, without any prior infection in other parts of the body. Common infectious agents causing primary encephalitis include viruses like herpes simplex virus (HSV), West Nile virus (WNV), and enteroviruses. HSV encephalitis is one of the most severe forms of primary encephalitis and requires immediate medical attention. It can lead to significant brain damage and neurological complications if not treated promptly. Thereby, driving the segment expansion.
Encephalitis Treatment Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market over the forecast period. Encephalitis cases occur throughout North America, with varying prevalence rates depending on the region and the type of encephalitis (e.g., viral, autoimmune). Viral encephalitis, such as herpes simplex encephalitis, has been reported to be one of the leading causes of sporadic encephalitis in the United States. Moreover, North America, particularly the United States, has been at the forefront of encephalitis research and clinical trials. Many academic institutions, pharmaceutical companies, and research organizations are actively involved in studying the pathogenesis of encephalitis, identifying new treatment modalities, and exploring potential vaccines. Thus, this is expected to drive the market growth in the region.
Encephalitis Treatment Market- Competitive Landscape:
Leading companies in the worldwide Encephalitis Treatment market are stepping up their R&D efforts to diversify their product offerings. Additionally, these market participants use strategic alliances and partnerships that promote growth. The key players operating in the market include Allergan, Merck & Co., Inc., Pfizer Inc., GlaxoSmithKline plc, Melinta Therapeutics LLC, Basilea Pharmaceutica Ltd., Abbott, F. Hoffmann-La Roche Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Novartis AG, Bayer AG, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin, AbbVie Inc., Cumberland Pharmaceuticals Inc., Eli Lilly and Company, Endo International plc, Zydus Cadila, and Fresenius Kabi AG.
Recent Developments:
- In August 2021, the Tick-Borne Encephalitis (TBE) vaccine, known as TICOVAC, was approved by the United States Food and Drug Administration (USFDA). In the wild, it can generate TBE virus-neutralizing antibodies. Albumin, a component of human blood, is present in TICOVAC. Virus transmission and variant Creutzfeldt-Jakob disease (vCJD) transmission are extremely unlikely due to effective donor screening and product processing procedures.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ENCEPHALITIS TREATMENT MARKET KEY PLAYERS
- Allergan
- Merck & Co., Inc.
- Pfizer Inc.
- GlaxoSmithKline plc
- Melinta Therapeutics LLC
- Basilea Pharmaceutica Ltd.
- Abbott
- Hoffmann-La Roche Ltd.
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd.
- Sanofi
- Novartis AG
- Bayer AG
- Sun Pharmaceutical Industries Ltd.
- Aurobindo Pharma
- Lupin
- AbbVie Inc.
- Cumberland Pharmaceuticals Inc.
- Eli Lilly and Company
- Endo International plc
- Zydus Cadila
- Fresenius Kabi AG
GLOBAL ENCEPHALITIS TREATMENT MARKET, BY TYPE
- Primary Encephalitis
- Secondary Encephalitis
GLOBAL ENCEPHALITIS TREATMENT MARKET, BY TREATMENT
- Antiviral Agents
- Steroid Injection
- Antibiotics
- Immunoglobulin Therapy
- Plasmapheresis
- Others
GLOBAL ENCEPHALITIS TREATMENT MARKET, BY SYMPTOMS
- Fever
- Drowsiness
- Headaches
- Personality Changes
- Irritability
- Confusion
- Weakness
- Seizures
- Others
GLOBAL ENCEPHALITIS TREATMENT MARKET, BY END USER
- Clinic
- Hospital
- Others
GLOBAL ENCEPHALITIS TREATMENT MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Encephalitis Treatment Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Encephalitis Treatment Market Snippet by Type
2.1.2. Encephalitis Treatment Market Snippet by Treatment
2.1.3. Encephalitis Treatment Market Snippet by Symptoms
2.1.4. Encephalitis Treatment Market Snippet by End User
2.1.5. Encephalitis Treatment Market Snippet by Country
2.1.6. Encephalitis Treatment Market Snippet by Region
2.2. Competitive Insights
3. Encephalitis Treatment Key Market Trends
3.1. Encephalitis Treatment Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Encephalitis Treatment Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Encephalitis Treatment Market Opportunities
3.4. Encephalitis Treatment Market Future Trends
4. Encephalitis Treatment Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Encephalitis Treatment Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Encephalitis Treatment Market Landscape
6.1. Encephalitis Treatment Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Encephalitis Treatment Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
7.1.2. Primary Encephalitis
7.1.3. Secondary Encephalitis
8. Encephalitis Treatment Market – By Treatment
8.1. Overview
8.1.1. Segment Share Analysis, By Treatment, 2022 & 2030 (%)
8.1.2. Antiviral Agents
8.1.3. Steroid Injection
8.1.4. Antibiotics
8.1.5. Immunoglobulin Therapy
8.1.6. Plasmapheresis
8.1.7. Others
9. Encephalitis Treatment Market – By Symptoms
9.1. Overview
9.1.1. Segment Share Analysis, By Symptoms, 2022 & 2030 (%)
9.1.2. Fever
9.1.3. Drowsiness
9.1.4. Headaches
9.1.5. Personality Changes
9.1.6. Irritability
9.1.7. Confusion
9.1.8. Weakness
9.1.9. Seizures
9.1.10. Others
10. Encephalitis Treatment Market – By End User
10.1. Overview
10.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
10.1.2. Clinic
10.1.3. Hospital
10.1.4. Others
11. Encephalitis Treatment Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
11.2. North America
11.2.1. Overview
11.2.2. Encephalitis Treatment Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.2.5. North America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.2.6. North America Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.2.7. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Encephalitis Treatment Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.3.9. Italy
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.9.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.3.9.4. Italy Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.3.9.5. Italy Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.3.9.6. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.3.10. United Kingdom
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.3.10.4. United Kingdom Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.3.10.5. United Kingdom Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.3.11. France
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.11.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.3.11.4. France Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.3.11.5. France Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.3.11.6. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.3.12. Russia
11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.12.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.3.12.3. Russia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.3.12.4. Russia Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.3.12.5. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.3.13. Netherlands
11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.13.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.3.13.3. Netherlands Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.3.13.4. Netherlands Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.3.13.5. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.3.14. Sweden
11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.14.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.3.15. Poland
11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.15.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.3.15.3. Poland Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.3.15.4. Poland Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.3.15.5. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.3.16. Rest of Europe
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.3.16.4. Rest of the Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.3.16.5. Rest of the Europe Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Encephalitis Treatment Key Manufacturers in Asia Pacific
11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.4.5. Asia Pacific Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.4.6. Asia Pacific Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.4.7. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.4.8. India
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.8.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.4.8.4. India Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.4.8.5. India Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.4.8.6. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.4.9. China
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.9.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.4.9.4. China Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.4.9.5. China Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.4.9.6. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.4.13. Thailand
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.13.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.4.13.4. Thailand Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.4.13.5. Thailand Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.4.13.6. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.4.14. Indonesia
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.14.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.4.14.4. Indonesia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.4.14.5. Indonesia Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.4.14.6. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.5. Latin America
11.5.1. Overview
11.5.2. Encephalitis Treatment Key Manufacturers in Latin America
11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.5.5. Latin America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.5.6. Latin America Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.5.7. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.6. Middle East and Africa
11.6.1. Overview
11.6.2. Encephalitis Treatment Key Manufacturers in Middle East and Africa
11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.6.5. Middle East and Africa Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.6.6. Middle East and Africa Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
12. Key Vendor Analysis- Encephalitis Treatment Industry
12.1. Competitive Dashboard
12.2. Company Profiles
12.2.1. Allergan
12.2.2. Merck & Co., Inc.
12.2.3. Pfizer Inc.
12.2.4. GlaxoSmithKline plc
12.2.5. Melinta Therapeutics LLC
12.2.6. Basilea Pharmaceutica Ltd.
12.2.7. Abbott
12.2.8. F. Hoffmann-La Roche Ltd.
12.2.9. Mylan N.V.
12.2.10. Teva Pharmaceutical Industries Ltd.
12.2.11. Sanofi
12.2.12. Novartis AG
12.2.13. Bayer AG
12.2.14. Sun Pharmaceutical Industries Ltd.
12.2.15. Aurobindo Pharma
12.2.16. Lupin
12.2.17. AbbVie Inc.
12.2.18. Cumberland Pharmaceuticals Inc.
12.2.19. Eli Lilly and Company
12.2.20. Endo International plc
12.2.21. Zydus Cadila
12.2.22. Fresenius Kabi AG
13. 360 Degree Analyst View
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
